Amir Nashat, PhD

Amir Nashat

Amir Nashat is a Partner in Polaris’ Boston office. He joined Polaris in 2002 and focuses on investments in healthcare. Amir currently represents Polaris as a Director of AgBiome, aTyr Pharmaceuticals (NASDAQ: LIFE), Fate Therapeutics (NASDAQ: FATE), Jnana Therapeutics, where he serves as CEO, Marauder Therapeutics, Metacrine Therapeutics, Morphic Therapeutic, Olivo Labs, Promedior Pharmaceuticals, Scholar…

Read More

Jason Tuschman

Jason Tuschman

Since 1997, Jason has developed digital marketing and consumer acquisition channels for some of the nation’s leading brands such as GEICO, Netflix, T-Mobile, Sony and many more. Jason started Red Spot Interactive with the intention of providing elective health care practices with the same ROI driven customer acquisition and automation capabilities that Fortune 500 clients…

Read More

Mary Fisher

Mary is the Chair and Chief Executive Officer at Colorescience, a former division of SkinMedica Inc. where she served as Chief Executive Officer from 2008 until 2012. She led the successful sale of the company to Allergan, Inc. for $350 million with the potential for another $25 million contingent on certain sales milestones. Mary has…

Read More

Diane Goostree

Diane Goostree

Diane Goostree has served as President and CEO of ALASTIN Skincare since joining the company in 2015. She has over 30 years of experience in the pharmaceutical and cosmeceutical industries. Ms. Goostree was a key executive, building SkinMedica’s physician-dispensed skincare business from 2002 onward in her role as Senior Vice President of Corporate Development. Prior…

Read More

Louis Bucky, MD, FACS

Louis P. Bucky, MD, is Clinical Professor of Surgery in the Division of Plastic Surgery at the University of Pennsylvania School of Medicine in Philadelphia. Dr. Bucky received his medical degree from Harvard Medical School in Boston, Massachusetts, and completed residencies in general and plastic surgery at Massachusetts General Hospital, also in Boston. He then…

Read More

Simeon Wall, Jr., MD, FACS

Simeon Wall

Simeon Wall Jr, MD is an aesthetic plastic surgeon in private practice and co-founder of SurgiStem Technologies, a medical device and research company focused on fat transplantation and stem cell technology. Dr. Wall Jr earned his undergraduate degree from The University of Texas at Austin, and his medical degree from The University of Texas Health…

Read More

Mark Pinsky, MD

Mark Pinsky

A graduate from The Ohio State University Medical School, Dr. Mark Pinsky performed his general surgery and plastic surgery training at the University of Texas Health Science Center in Houston, including MD Anderson Cancer Hospital. He is a member of several plastic surgery societies and a Diplomate, American Board of Plastic Surgery. Serving as both…

Read More

Philippe Schaison

Dr. Schaison is a CEO, Global President and Chief Commercial Officer in consumer healthcare, consumer goods and retail sectors (Asia, South America and Europe). His experience includes running a $2.5B+ business growing 17% a year at Allergan, acquiring and integrating +$2B organization, and leading global organizations to implement successful operations and drive profitability. His strong…

Read More

Dan Browne

Daniel Brown

Dan Browne is a co-founder of the company and has served as our President, Chief Executive Officer and a member of the board of directors since operations commenced in 2002. Prior to starting Revance, Mr. Browne served as President and Chief Executive Officer of Neomend, Inc., a biologics and biomaterials company; he served as President…

Read More